{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:14:56Z","timestamp":1790806496833,"version":"4.1.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["RD16\/0016"],"award-info":[{"award-number":["RD16\/0016"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PI15\/00088"],"award-info":[{"award-number":["PI15\/00088"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["COMBACTE-MAGNET"],"award-info":[{"award-number":["COMBACTE-MAGNET"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.00685","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T06:40:37Z","timestamp":1523601637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":252,"title":["The Versatile Mutational Resistome of Pseudomonas aeruginosa"],"prefix":"10.3389","volume":"9","author":[{"given":"Carla","family":"L\u00f3pez-Causap\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Cabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"del Barrio-Tofi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1128\/AAC.00257-10","article-title":"Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.","volume":"54","author":"Alvarez-Ortega","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1128\/AAC.46.11.3406-3411.2002","article-title":"Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD.","volume":"46","author":"Bagge","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1128\/AAC.00893-09","article-title":"Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.","volume":"53","author":"Barrow","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1586\/eri.12.36","article-title":"Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy.","volume":"10","author":"Bassetti","year":"2012","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1128\/AAC.00825-15","article-title":"Mutations in \u03b2-Lactamase AmpC increase resistance of Pseudomonas aeruginosa isolates to antipseudomonal cephalosporins.","volume":"59","author":"Berrazeg","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01835-17","article-title":"Mutations in gene fusA1 as a novel mechanism of aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.","volume":"62","author":"Bolard","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1128\/AAC.01581-12","article-title":"Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.","volume":"57","author":"Bruchmann","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1128\/AAC.02462-13","article-title":"Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.","volume":"58","author":"Cabot","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1128\/AAC.02676-15","article-title":"Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates.","volume":"60","author":"Cabot","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1128\/AAC.01720-16","article-title":"Deciphering the resistome of the widespread Pseudomonas aeruginosa Sequence Type 175 international high-risk clone through whole-genome sequencing.","volume":"60","author":"Cabot","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/jac\/dkx399","article-title":"Activity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model.","volume":"73","author":"Cai","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.1128\/JB.00748-09","article-title":"The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa.","volume":"191","author":"Casta\u00f1eda-Garc\u00eda","year":"2009","journal-title":"J. Bacteriol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1093\/jac\/dku048","article-title":"Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.","volume":"69","author":"Castanheira","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01651-16","article-title":"Penicillin-Binding Protein 3 is essential for growth of Pseudomonas aeruginosa.","volume":"61","author":"Chen","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1128\/JB.01050-12","article-title":"Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients.","volume":"194","author":"Chung","year":"2012","journal-title":"J. Bacteriol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1126\/science.1120800","article-title":"Sampling the antibiotic resistome.","volume":"311","author":"D\u2019Costa","year":"2006","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01589-17","article-title":"Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain.","volume":"61","author":"Del Barrio-Tofi\u00f1o","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1128\/JCM.43.3.1198-1204.2005","article-title":"Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa.","volume":"43","author":"Deplano","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00981-15","article-title":"Selective sweeps and parallel pathoadaptation drive Pseudomonas aeruginosa evolution in the cystic fibrosis lung.","volume":"6","author":"Diaz Caballero","year":"2015","journal-title":"mBio"},{"key":"B20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1574-6976.2010.00237.x","article-title":"Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease.","volume":"35","author":"D\u00f6ring","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1128\/AAC.00035-09","article-title":"Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa.","volume":"53","author":"D\u00f6tsch","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00043-17","article-title":"Rapid and consistent evolution of colistin resistance in extensively drug-resistant Pseudomonas aeruginosa during morbidostat culture.","volume":"61","author":"D\u00f6\u00dfelmann","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1128\/AAC.00704-06","article-title":"Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.","volume":"51","author":"El\u2019Garch","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001619","article-title":"The neglected intrinsic resistome of bacterial pathogens.","volume":"3","author":"Fajardo","year":"2008","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1128\/AAC.00434-16","article-title":"Dynamics of mutations during development of resistance by Pseudomonas aeruginosa against five antibiotics.","volume":"60","author":"Feng","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/jac\/dkt098","article-title":"Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.","volume":"68","author":"Fournier","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx424","article-title":"Mechanisms leading to in vivo ceftolozane\/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.","author":"Fraile-Ribot","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01117-17","article-title":"In vivo emergence of resistance to novel cephalosporin-\u03b2-Lactamase inhibitor combinations through the duplication of amino acid D149 from OXA-2 \u03b2-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa.","volume":"61","author":"Fraile-Ribot","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.1128\/AAC.00724-16","article-title":"Molecular epidemiology of mutations in antimicrobial resistance loci of Pseudomonas aeruginosa isolates from airways of Cystic Fibrosis patients.","volume":"60","author":"Greipel","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1128\/AAC.01252-13","article-title":"Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.","volume":"58","author":"Gu\u00e9nard","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1128\/AAC.02353-12","article-title":"Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.","volume":"57","author":"Gutu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/cid\/cix182","article-title":"Ceftolozane-Tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa infections: clinical effectiveness and evolution of resistance.","volume":"65","author":"Haidar","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"22002","DOI":"10.1073\/pnas.1013092107","article-title":"Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa.","volume":"107","author":"Han","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1111\/1462-2920.13336","article-title":"Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.","volume":"18","author":"Hocquet","year":"2016","journal-title":"Environ. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2017.12.012","article-title":"Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections.","volume":"172","author":"Imamovic","year":"2017","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijantimicag.2017.02.026","article-title":"Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa.","volume":"50","author":"Jaillard","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mrfmmm.2009.10.015","article-title":"Molecular characterization of Rif(r) mutations in Pseudomonas aeruginosa and Pseudomonas putida.","volume":"683","author":"Jatsenko","year":"2010","journal-title":"Mutat. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ijantimicag.2016.11.029","article-title":"Resistance to polymyxins in Gram-negative organisms.","volume":"49","author":"Jeannot","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00517-17","article-title":"Evolved aztreonam resistance is multifactorial and can produce hypervirulence in Pseudomonas aeruginosa.","volume":"8","author":"Jorth","year":"2017","journal-title":"mBio"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1128\/AAC.49.11.4733-4738.2005","article-title":"Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.","volume":"49","author":"Juan","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/femsre\/fux043","article-title":"Diversity and regulation of intrinsic \u03b2-lactamases from non-fermenting and other Gram-negative opportunistic pathogens.","volume":"41","author":"Juan","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02445-17","article-title":"Constitutive activation of MexT by amino acid substitutions results in MexEF-OprN overproduction in clinical isolates of Pseudomonas aeruginosa.","author":"Juarez","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00585-17","article-title":"Toxic electrophiles induce expression of the multidrug efflux pump MexEF-OprN in Pseudomonas aeruginosa through a novel transcriptional regulator, CmrA.","volume":"61","author":"Juarez","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1128\/AAC.03954-14","article-title":"The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility.","volume":"59","author":"Kos","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1128\/AAC.03057-14","article-title":"Avibactam and class C \u03b2-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance.","volume":"58","author":"Lahiri","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mbo3.226","article-title":"AmgRS-mediated envelope stress-inducible expression of the mexXY multidrug efflux operon of Pseudomonas aeruginosa.","volume":"4","author":"Lau","year":"2015","journal-title":"Microbiol. Open"},{"key":"B47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diagmicrobio.2013.11.027","article-title":"Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.","volume":"78","author":"Lee","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.","volume":"22","author":"Lister","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02583-17","article-title":"Evolution of the Pseudomonas aeruginosa aminoglycoside mutational resistome in vitro and in the cystic fibrosis setting.","author":"L\u00f3pez-Causap\u00e9","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05621-5","article-title":"Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone.","volume":"7","author":"L\u00f3pez-Causap\u00e9","year":"2017","journal-title":"Sci. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1128\/AAC.49.8.3382-3386.2005","article-title":"Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.","volume":"49","author":"Maci\u00e1","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01592-14","article-title":"Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa.","volume":"5","author":"Markussen","year":"2014","journal-title":"mBio."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin.","volume":"15","author":"Michalopoulos","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1128\/AAC.01198-13","article-title":"High-level pacidamycin resistance in Pseudomonas aeruginosa is mediated by an opp oligopeptide permease encoded by the opp-fabI operon.","volume":"57","author":"Mistry","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1128\/AAC.05829-11","article-title":"PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.","volume":"56","author":"Moskowitz","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000353","article-title":"Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.","volume":"5","author":"Moya","year":"2009","journal-title":"PLoS Pathog."},{"key":"B58","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1128\/AAC.00519-11","article-title":"Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.","volume":"55","author":"Mulet","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1128\/AAC.01252-10","article-title":"A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and \u03b2-lactams in Pseudomonas aeruginosa.","volume":"55","author":"Muller","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01847-2016","article-title":"Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients.","volume":"49","author":"Mustafa","year":"2017","journal-title":"Eur. Respir. J."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00643","article-title":"Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria.","volume":"5","author":"Olaitan","year":"2014","journal-title":"Front. Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","article-title":"High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.","volume":"288","author":"Oliver","year":"2000","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","article-title":"The increasing threat of Pseudomonas aeruginosa high-risk clones.","volume":"2","author":"Oliver","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"B64","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tim.2015.02.009","article-title":"Collateral sensitivity of antibiotic-resistant microbes.","volume":"23","author":"P\u00e1l","year":"2015","journal-title":"Trends Microbiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/thoraxjnl-2015-208027","article-title":"Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.","volume":"72","author":"Prickett","year":"2017","journal-title":"Thorax"},{"key":"B66","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ijantimicag.2014.12.029","article-title":"Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.","volume":"45","author":"Richardot","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010193","article-title":"Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.","volume":"5","author":"Rodr\u00edguez-Rojas","year":"2010","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1128\/AAC.00507-08","article-title":"Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.","volume":"52","author":"Schurek","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijantimicag.2010.11.019","article-title":"Adaptive resistance to cationic compounds in Pseudomonas aeruginosa.","volume":"37","author":"Skiada","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-272","article-title":"A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.","volume":"11","author":"Suarez","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijantimicag.2015.09.014","article-title":"Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa.","volume":"47","author":"Vestergaard","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/S0140-6736(03)13644-6","article-title":"Nosocomial infections in adult intensive-care units.","volume":"361","author":"Vincent","year":"2003","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1574-6976.2011.00268.x","article-title":"Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.","volume":"35","author":"Woodford","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2001586","article-title":"History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment.","volume":"15","author":"Yen","year":"2017","journal-title":"PLoS Biol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T13:01:02Z","timestamp":1660914062000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":74,"alternative-id":["10.3389\/fmicb.2018.00685"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.00685","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"article-number":"685"}}